Chin Augmentation (Mentoplasty) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Chin augmentation, medically termed mentoplasty or genioplasty, is a surgical or minimally invasive procedure performed to enhance the projection, height, width, or overall contour of the chin to achieve improved facial harmony and aesthetic balance. The chin and lower jaw (mandible) form the foundation of the lower facial third, and its relationship to the nose, lips, and midface critically determines the overall aesthetic impression of the profile. A recessed or microgenia (abnormally small) chin creates the appearance of a disproportionately large nose, weak jawline, submental fat excess, and an unflattering profile despite otherwise normal facial features. Conversely, an appropriately projecting, well-defined chin frames the face, accentuates the cervicomental angle, and contributes to a perception of strength, confidence, and balance.

Chin augmentation is among the most consistently performed cosmetic surgical procedures globally. According to the American Society of Plastic Surgeons, chin augmentation has experienced among the fastest growth of any facial cosmetic procedure in the past decade, correlating with increased self-awareness from video conferencing and social media. Rhinoplasty surgeons routinely note that up to 30–40% of patients presenting for primary rhinoplasty have clinically significant chin deficiency — correction of which through simultaneous augmentation often produces more dramatic facial balance improvement than rhinoplasty alone.

Chin augmentation is achieved through two principal surgical strategies. Alloplastic chin implantation involves placement of a solid silicone, porous polyethylene, or PEEK prosthesis in a sub-periosteal pocket over the anterior mandibular symphysis, and is the most commonly performed method due to its simplicity, short operative time, predictable outcomes, and ease of reversibility. Sliding genioplasty (osseous genioplasty) is an osteotomy-based technique in which the chin bone is cut, repositioned in multiple dimensions (anteriorly, inferiorly, laterally, or in rotation), and fixed with titanium plates — offering superior versatility for complex asymmetric or multi-dimensional corrections. Non-surgical approaches using injectable dermal fillers provide temporary, reversible augmentation for patients preferring to avoid surgery or as a preview of surgical results.

Chin augmentation addresses a spectrum of anatomical and functional concerns affecting the lower facial third:

• Microgenia (chin hypoplasia): Congenitally underdeveloped or genetically small chin producing a recessed profile and imbalanced facial proportions. May occur in isolation or as part of micrognathia (underdeveloped mandible), the latter often requiring combined orthodontic and orthognathic treatment.
• Pseudomacrogenia (apparent nose prominence): Normal-sized nose appearing disproportionately large on profile because the chin is recessed relative to the forehead vertical; chin augmentation often achieves greater aesthetic improvement in perceived nose-face balance than rhinoplasty alone.
• Cervicomental angle deficiency: A weak, poorly defined jaw-neck angle — often accompanied by submental fat and early jowling — that is dramatically improved by increasing horizontal chin projection, which stretches the anterior neck soft tissues and defines the cervicomental angle.
• Post-weight loss facial changes: Significant weight loss leads to loss of facial fat and soft tissue descent, making skeletal deficiencies that were previously masked by subcutaneous fat more apparent. Chin augmentation restores structural projection in this context.
• Facial asymmetry: Asymmetric chin position or projection (vertical or horizontal) resulting from congenital asymmetry, prior trauma, or prior surgery. Sliding genioplasty provides three-dimensional correction unavailable with standard symmetric implants.
• Facial feminisation or masculinisation: Chin shape is a critical gender-dimorphic feature. Feminisation involves reducing chin width and height for a narrower, softer contour; masculinisation involves increasing projection and width for a broader, squarer appearance. Both are components of facial gender-affirming surgery.
• Post-traumatic mandibular deformity: Residual deformity following inadequately reduced mandibular symphyseal fracture may be addressed with implant augmentation or genioplasty repositioning.

Ideal candidates for chin augmentation present with the following characteristics:

• Adults with fully developed facial skeletal maturity (typically 17–18 years; orthodontic clearance required in adolescents with borderline jaw development)
• Objectively documented chin deficiency on clinical facial analysis — Ricketts E-plane (chin should ideally be 0–2 mm behind a line from nasal tip to soft tissue pogonion), Gonzalez-Ulloa zero meridian, or three-dimensional photogrammetric analysis
• Normal dental occlusion (Class I malocclusion) — patients with significant dental malocclusion (Class II or Class III) are best treated first with orthodontics and orthognathic surgery rather than cosmetic chin implantation, which addresses aesthetics but not the underlying occlusal relationship
• Physically healthy with no active skin or oral infection, well-controlled systemic disease, and adequate soft-tissue chin pad thickness for implant coverage (>5 mm on preoperative soft-tissue imaging)
• Non-smoker or ability to cease smoking for minimum 4 weeks pre- and post-operatively
• Psychologically stable with clearly articulated, realistic goals; not seeking surgical correction of an anatomically normal chin driven by perceived social pressure without clear objective deficiency

Contraindications and higher-risk presentations:

• Significant dental malocclusion (Class II or Class III) — skeletal correction with orthodontics and orthognathic surgery (Le Fort osteotomy + sagittal split ramus osteotomy) is preferred; cosmetic implant placement does not correct functional bite problems
• Very thin soft-tissue chin pad (<4 mm) — inadequate soft tissue coverage increases implant edge visibility, migration risk, and skin erosion risk
• History of mandibular infection, osteomyelitis, or radiation to the jaw field
• Severe coagulopathy or anticoagulant therapy that cannot be safely managed perioperatively
• Active acne, skin infection, or herpes labialis in the procedure site at time of surgery
• Body dysmorphic disorder (BDD) — surgical intervention typically worsens BDD outcomes; psychiatric evaluation is required when BDD is clinically suspected
• Prior chin surgery with significant periosteal scarring (revision implant surgery is technically more demanding and has a higher complication rate)

Multiple surgical and non-surgical approaches exist for chin augmentation, offering differing degrees of dimensional correction, permanence, and invasiveness:

• Solid silicone chin implants (most common): Medical-grade solid silicone prostheses are available in an extensive range of anatomical shapes and sizes — anatomic (central projection), extended anatomic (broader lateral extension for jawline enhancement), chin-cheek or total jawline implants (continuous mandibular augmentation from chin to angle), and custom designs. The implant is placed in a meticulously dissected sub-periosteal pocket over the anterior mandibular chin pad via a submental (under the chin) or intraoral (inside the mouth) incision. Sub-periosteal placement provides the most stable position with minimal migration. Advantages: straightforward technique, predictable results, reversible if needed, short operative time (30–60 minutes). Leading manufacturers: Implantech, Stryker, Surgiform, Spectrum Designs.
• Porous polyethylene (Medpor) implants: Rigid, open-pored biomaterial allowing fibrovascular tissue ingrowth for biological integration. Very stable once integrated (lower migration rates than silicone), but significantly more difficult to remove if revision or explantation is required. Preferred for complex facial reconstruction and large-volume corrections.
• Custom 3D-printed implants: Designed from pre-operative CT data in titanium, PEEK, or silicone to provide precise, individualised anatomical fit. Required for complex asymmetric corrections, post-traumatic deformities, or patients seeking comprehensive mandibular jawline augmentation from chin to angle. 4–8 weeks production lead time; adds significant cost over off-the-shelf implants.
• Sliding genioplasty (osseous genioplasty): An osteotomy-based procedure in which the surgeon makes a horizontal cut in the mandibular symphysis below the dental roots, mobilises the chin bone segment, and repositions it anteriorly, inferiorly (to lengthen the chin), laterally (to correct asymmetry), or superiorly (to shorten an overly long chin), fixing it with titanium miniplates and screws. Advantages: multi-dimensional correction not achievable with implants (can simultaneously advance, drop, and de-rotate), uses autologous bone, no foreign body implant. Disadvantages: longer operative time, higher complexity, slower recovery, requires general anaesthesia. Preferred when horizontal advancement exceeds 10 mm, vertical change is required, or significant asymmetry correction is needed.
• Non-surgical chin augmentation with dermal fillers: Hyaluronic acid (HA) fillers (Juvederm Voluma, Restylane Defyne) or calcium hydroxylapatite (Radiesse) are injected deep (sub-periosteal or supraperiosteal) to increase chin projection, refine contour, or create a sharper cervicomental angle. Procedure time 15–30 minutes; no downtime; fully reversible (HA with hyaluronidase). Limitations: temporary (12–18 months), cannot correct bony asymmetry, requires repeat treatment, and can produce vascular complications (arterial occlusion) in inexperienced hands due to proximity of the inferior labial and mental arteries. Best for mild deficiency or as a 'preview' of surgical results.

Chin augmentation is associated with high patient satisfaction and objectively measurable improvements in facial aesthetics:

• High patient satisfaction: Chin implant surgery consistently achieves patient satisfaction rates of 90–95% in peer-reviewed outcome studies when performed by experienced surgeons on appropriately selected candidates. Patient-reported outcome measures (PROMs) using validated instruments (FACE-Q, Surgical Outcomes System) demonstrate significant improvements in appearance-related confidence and social functioning at 6-month follow-up.
• Dramatic profile improvement: Photographic analysis consistently demonstrates improved cervicomental angle definition, increased apparent neck length, reduction in the appearance of submental fullness, and improved nose-to-chin aesthetic balance following augmentation. Patients often report that others notice an improvement in overall appearance without identifying the specific surgical change.
• Simultaneous rhinoplasty synergy: When performed concurrently with rhinoplasty, chin augmentation significantly enhances the overall facial balance outcome. Published studies demonstrate that combined rhinoplasty-mentoplasty achieves superior patient and panel-rated aesthetic outcomes compared to rhinoplasty alone in patients with co-existing chin deficiency.
• Rapid recovery: Chin implant surgery is typically performed as a day-case procedure. Most patients are socially presentable (with minimal camouflage) within 7–10 days and fully recovered within 4–6 weeks.
• Durability: Solid silicone chin implants are permanent, requiring no replacement under normal circumstances. Long-term studies following patients for 10–20 years demonstrate stable aesthetic outcomes, with very low rates of late migration or capsular contracture compared to breast implants.
• Jawline enhancement: Extended or total jawline implants that augment from chin to mandibular angle create a defined, sculpted lower facial contour — a result increasingly sought in male patients pursuing facial masculinisation or general jawline definition unavailable through non-surgical means.

Chin augmentation has an excellent overall safety profile, but specific complications must be understood prior to consent:

• Implant malposition or asymmetry: The most common complication requiring revision, occurring in approximately 5–8% of cases. Lateral displacement from the sub-periosteal pocket, asymmetric pocket dissection, or seroma-related float produces visible or palpable off-midline position. Revision repositioning under local anaesthesia corrects most cases.
• Infection: Overall infection rates of 1–2%, slightly higher with intraoral access (oral flora proximity) than with submental (external) incision. May require temporary implant removal, antibiotic therapy, and re-implantation at 3–6 months.
• Mental nerve injury (sensory change): The mental nerve, which exits the mandible at the mental foramen and provides sensation to the lower lip and chin skin, is at risk during sub-periosteal pocket dissection. Transient numbness or tingling of the lower lip occurs in 15–25% of patients; persistent significant numbness beyond 6 months in <3%. Anatomical knowledge and intraoperative nerve identification minimise this risk.
• Bone resorption: Chronic pressure from the implant on the underlying mandibular cortex produces a degree of bone resorption in a significant percentage of patients when assessed radiographically at 5–10 years. Usually modest and clinically insignificant, but in rare cases with larger implants may alter the position of dental roots or produce a pressure groove in the mandible visible on imaging.
• Implant palpability or visibility: Thin-skinned patients or those with inadequate soft-tissue chin pad thickness may feel or occasionally see implant edges. Proper implant size selection and thorough sub-periosteal dissection minimise this. Revision with a smaller implant or fat grafting over the implant edges corrects most cases.
• Wound dehiscence: Intraoral wound opening is uncommon (<2%) and typically heals with conservative management (antiseptic rinses, local wound care). External submental incisions heal with a fine, well-concealed scar in the natural submental crease in the vast majority of patients.
• Haematoma: Uncommon (<1%); small collections resolve spontaneously; larger haematomas may require aspiration or surgical drainage to prevent secondary infection.

Immediate post-operative period (Days 1–3): Expected swelling and bruising in the chin and lower lip are most pronounced during the first 48–72 hours. An external compression dressing or surgical tape strips are applied for 3–5 days to minimise oedema and haematoma formation. Pain is typically mild to moderate and well-controlled with oral analgesics (NSAIDs and/or acetaminophen; short-course opioids for breakthrough pain). With intraoral incisions, patients follow a liquid or soft diet for 7–10 days and use chlorhexidine mouth rinse after each meal. Head elevation (30–45°) during sleep reduces swelling.

Early recovery (Days 4–14): Most swelling peaks at 48–72 hours and begins to subside steadily. Patients can typically shower from day 2. External submental sutures are removed at 5–7 days. By day 7–10, most patients can return to social and professional activities, though visible residual swelling may require a further 1–2 weeks to become imperceptible to casual observers. Dental hygiene is maintained with a soft-bristled toothbrush; aggressive jaw movements are minimised during the first 2 weeks to avoid stress on the implant pocket.

Intermediate recovery (Weeks 2–6): Progressive resolution of firmness and fullness as post-operative oedema continues to dissipate. Final contour of the chin is not fully apparent until 6–8 weeks when residual swelling has resolved. Strenuous physical exercise, contact sports, and any activity risking blunt chin trauma are restricted for 6 weeks to allow maturation of the fibrous capsule around the implant, which stabilises it in position.

Long-term follow-up: Standard post-operative review at 1 week (suture removal if external), 6 weeks (clinical and photographic assessment of final result), and 6 months. Patients are informed that no routine radiographic surveillance is required for standard silicone implants unless specific symptoms develop. Implants do not require prophylactic antibiotic coverage for routine dental procedures after the initial 3-month osseointegration period (unlike joint replacements). Any future facial trauma to the chin should prompt clinical evaluation and imaging to assess implant position. Aesthetic longevity is excellent — the vast majority of patients require no further intervention for 10–20+ years.

Chin augmentation is classified as elective cosmetic surgery and is not covered by public health insurance or standard private insurance policies (exceptions: functional/reconstructive indications following trauma, tumour resection, or orthognathic surgical correction of malocclusion). Representative costs for standard chin implant augmentation:

• United States: USD 3,500–8,000 (surgeon fee, anaesthesia, facility, implant)
• United Kingdom (private): GBP 2,800–6,000
• Australia: AUD 5,000–10,000
• India (Mumbai, Delhi, Bengaluru): USD 1,200–3,000 at NABH/JCI-accredited cosmetic surgery centres
• Thailand (Bangkok): USD 2,000–4,500
• Turkey (Istanbul): USD 1,800–4,000 (packages often include hotel and airport transfer)
• South Korea (Seoul): USD 2,500–6,000 (world-leading volume of facial skeletal procedures including genioplasty)
• Mexico (border cities): USD 2,000–4,500

Factors influencing cost:

• Procedure type: sliding genioplasty is more expensive (longer operative time, titanium fixation hardware, specialised surgical team) than implant augmentation — add 50–100% for genioplasty
• Custom 3D-printed implants add USD 3,000–8,000 over standard off-the-shelf implants
• Combination with rhinoplasty, facelift, or neck liposuction — package pricing typically reduces cost per procedure
• Surgeon experience and subspecialisation
• Facility type (outpatient surgery centre vs. hospital)
• Anaesthesia: local with IV sedation vs. general anaesthesia (additional anaesthesiologist fee)
• Geographic location and local market pricing within each country

A range of surgical and non-surgical alternatives exist depending on the degree of chin deficiency, patient preference, and goals:

• Hyaluronic acid (HA) dermal fillers: The most popular non-surgical alternative. Injectable HA products (Juvederm Voluma, Restylane Defyne, Teosyal RHA) placed sub-peristeoally or supraperiosteoally can increase chin projection by 4–8 mm, refine contour, and create sharper cervicomental definition. Advantages: no surgery, no downtime, fully reversible with hyaluronidase, immediate visible result. Disadvantages: temporary (12–24 months), repeated treatments required, cumulative cost approaches or exceeds surgical cost after 3–5 years. Vascular complications (arterial occlusion) are rare but serious in inexperienced hands — insist on a physician injector with specific training in lower face anatomy.
• Calcium hydroxylapatite (CaHA) filler (Radiesse): A slightly firmer bio-stimulatory filler providing immediate projection and stimulating collagen neogenesis. Duration of 12–18 months. Not reversible (no antidote), so precise placement is critical. Often preferred for the chin due to its firmer consistency better matching the tissue character of the chin pad.
• Sliding osseous genioplasty: For patients requiring large horizontal advancements (>8–10 mm), multi-dimensional correction (combined horizontal advancement and vertical lengthening), or complex asymmetry correction, osteotomy-based genioplasty is superior to any implant approach. Also preferred by surgeons and patients averse to any foreign body implant, as it uses the patient's own bone. Recovery is longer (6–8 weeks vs. 3–4 weeks for implant), with more pronounced initial swelling, but the correction is permanent with no risk of implant-related complications.
• Orthognathic surgery (combined with orthodontics): When chin deficiency co-exists with dental malocclusion (Class II bite — lower jaw set back relative to upper), the appropriate comprehensive treatment is orthodontic alignment followed by sagittal split mandibular advancement osteotomy ± Le Fort I osteotomy. This corrects both the functional bite and the aesthetic skeletal position. Purely cosmetic chin implants in a patient with underlying malocclusion do not correct the functional problem.
• Neck liposuction (submental liposuction): For patients in whom the appearance of a weak chin is predominantly due to submental fat accumulation rather than true skeletal deficiency, liposuction of the submental area markedly improves cervicomental angle definition without implant surgery. High-definition liposuction with skin tightening (BodyTite, radiofrequency-assisted lipolysis) provides further definition. Often combined with chin augmentation for optimal result when both components are present.
• Kybella (deoxycholic acid) injections: Non-surgical fat reduction of the submental area via injectable deoxycholic acid. Requires multiple treatment sessions (typically 2–4), with progressive fat reduction over months. Not a substitute for skeletal chin augmentation but appropriate for isolated submental fat in patients with adequate bony chin projection.